- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05876624
The Connection Between Personality, Burnout, and Hypertension in Nigerian Bank Employees
May 17, 2023 updated by: Lawrence Ugwu, Renaissance University Ugbawka, Enugu
High Stakes, High Pressure: The Connection Between Personality, Burnout, and Hypertension in Nigerian Bank Employees
This is a longitudinal study which we plan to examine the link between personality traits, burnout, and hypertension in bank employees in South-eastern Nigeria
Study Overview
Status
Enrolling by invitation
Conditions
Intervention / Treatment
Detailed Description
This proposed longitudinal study aims to examine the relationship between personality traits, burnout, and hypertension in bank employees in South-eastern Nigeria, where hypertension is a significant public health issue.
The study will involve bankers as participants, who will be asked to complete self-report questionnaires and measure their blood pressure over four weeks.
The research seeks to determine if personality differences and burnout levels contribute to hypertension risk in this population.
By understanding the role of psychosocial factors in hypertension risk, the study hopes to provide recommendations for workplace adjustments that could improve employee well-being and reduce hypertension risk among Nigerian bank employees.
Study Type
Observational
Enrollment (Estimated)
600
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Enugu, Nigeria, 01153
- Renaissance University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
N/A
Sampling Method
Non-Probability Sample
Study Population
all Staff of commercial banks in Nigeria
Description
Inclusion Criteria:
- Any staff of the Bank
Exclusion Criteria:
- Non Staff
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Blood Pressure
Time Frame: 20 minutes
|
Blood Pressure measurement
|
20 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Lawrence E Ugwu, Renaissance University Ugbawka Enugu Nigeria
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
May 22, 2023
Primary Completion (Estimated)
June 19, 2023
Study Completion (Estimated)
July 10, 2023
Study Registration Dates
First Submitted
May 17, 2023
First Submitted That Met QC Criteria
May 17, 2023
First Posted (Actual)
May 25, 2023
Study Record Updates
Last Update Posted (Actual)
May 25, 2023
Last Update Submitted That Met QC Criteria
May 17, 2023
Last Verified
May 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RenaissanceU
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
We No plan of sharing the data.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
BayerCompletedPrimary HypertensionChina
-
Columbia UniversityAgency for Healthcare Research and Quality (AHRQ)Active, not recruitingWhite Coat Hypertension | Hypertension,EssentialUnited States
-
Addpharma Inc.Completed
-
Universidade Federal de Santa MariaCompletedHealthy Volunteers | Hypertension, EssentialBrazil
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldCompletedIdiopathic Pulmonary Arterial Hypertension | Chronic Thromboembolic Pulmonary HypertensionUnited Kingdom
-
China Academy of Chinese Medical SciencesGuang'anmen Hospital of China Academy of Chinese Medical SciencesCompletedHypertension, Resistant to Conventional Therapy | Primary HypertensionChina
-
Cytos Biotechnology AGCompletedMild Essential Hypertension | Moderate Essential HypertensionSwitzerland
Clinical Trials on Blood Pressure measurement
-
Kaiser PermanentePatient-Centered Outcomes Research InstituteCompleted
-
Summit Doppler Systems, Inc.The Cleveland ClinicCompletedPeripheral Arterial DiseaseUnited States
-
Hospital Clinic of BarcelonaRecruitingArterial Hypertension | Frailty Syndrome | Heart Failure With Preserved Ejection Fraction | Comorbidities and Coexisting ConditionsSpain
-
University Hospital OlomoucCompleted
-
Assistance Publique - Hôpitaux de ParisRecruiting
-
Albany Medical CollegeCompleted
-
BiospectalCSEM Centre Suisse d'Electronique et de Microtechnique SA - Recherche et...UnknownBlood PressureSwitzerland
-
Summit Doppler Systems, Inc.The Cleveland ClinicCompletedPeripheral Arterial DiseaseUnited States
-
Mount Carmel Health SystemAtCor Medical, Inc.RecruitingPregnancy Related | Pre-Eclampsia | Gestational HypertensionUnited States